Zejun Wang, Huajun Zhang, Jia Lu, K. Xu, Cheng Peng, Jing Guo, Xiaowei Gao, X. Wan, Wenhui Wang, Chao Shan, Suyun Zhang, Jie Wu, An-Na Yang, Yan Zhu, Ao Xiao, Lei Zhang, L. Fu, Hao-rui Si, Q. Cai, Xinglou Yang, Lei You, Yan-Ping Zhou, Jing Liu, De-Qing Pang, W. Jin, Xiao-Yu Zhang, Sheng-li Meng, Yunxiao Sun, U. Desselberger, Jun-zhi Wang, Xinguo Li, Kai Duan, Changgui Li, Miao Xu, Zhènglì Shí, Zhiming Yuan, Xiao-Ming Yang, S. Shen (2020)
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal modelsEmerging Microbes & Infections, 9
(1997)
International Committee of Harmonization (ICH), 1997, Non-clinical safety studies for the performance of human clinical trials for Pharmaceuticals
N. Fraleigh, Reynaldo Oliva, Jordan Lewicky, Alexandrine Martel, R. Acevedo, García-Rivera Dagmar, Hoang-Thanh Le (2019)
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routesPLoS ONE, 14
R. Forster (2012)
Study designs for the nonclinical safety testing of new vaccine products.Journal of pharmacological and toxicological methods, 66 1
(1999)
Humane Endpoints in Animal Experimentation for Biomedical Research
Reynaldo Oliva-Hernández, Mildrey Fariñas-Medina, Tamara Hernández-Salazar, J. Infante-Bourzac, Darcy Núñez-Martínez, Alex Quintero-Pérez, G. Sierra-González (2019)
Single dose toxicity non-clinical evaluation of the anti-meningococcal vaccine VA-MENGOC-BC ® in Sprague Dawley rats to extend its shelf-life to 36 months
Alexander Batista-Duharte, E. Lindblad, E. Oviedo-Orta (2011)
Progress in understanding adjuvant immunotoxicity mechanisms.Toxicology letters, 203 2
N. Doremalen, T. Lambe, Alexandra Spencer, Sandra Belij-Rammerstorfer, Jyothi Purushotham, J. Port, V. Avanzato, T. Bushmaker, A. Flaxman, M. Ulaszewska, F. Feldmann, E. Allen, H. Sharpe, Jonathan Schulz, M. Holbrook, A. Okumura, Kimberly Meade-White, L. Pérez-Pérez, N. Edwards, D. Wright, Cameron Bissett, Ciarán Gilbride, Brandi Williamson, Rebecca Rosenke, Dan Long, Alka Ishwarbhai, Reshma Kailath, Louisa Rose, S. Morris, Claire Powers, J. Lovaglio, P. Hanley, D. Scott, G. Saturday, E. Wit, S. Gilbert, V. Munster (2021)
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaquesNature, 590
Reynaldo Oliva-Hernández, Juan Infante-Bourzac, Luis García-Imías, Hilda García-Sánchez, Bárbara Cedré-Marrero, V. Sierra-González (2020)
Ensayo de inmunogenicidad y toxicidad aguda del candidato vacunal contra el cólera vax-COLER®VacciMonitor, 29
(2016)
The Guide for the Care and Use of Laboratory Animals.ILAR journal, 57 2
(2011)
quantifying pain in the laboratory rat via facial expressions. Molecular Pain, Jul 2011,29;7:55
Fangjia Lu, H. Hogenesch (2013)
Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant.Vaccine, 31 37
J. Draize, G. Woodard, H. Calvery (1944)
METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANESThe Journal of Pharmacology and Experimental Therapeutics
(2013)
Guidelines on the evaluation of vaccine adjuvants and adjuvanted vaccine
Zhihui Liang, Haoru Zhu, Xin Wang, Bo-Tao Jing, Zifan Li, Xinyu Xia, Hong-wu Sun, Yun Yang, Weiting Zhang, Li Shi, H. Zeng, Bingbing Sun (2020)
Adjuvants for Coronavirus VaccinesFrontiers in Immunology, 11
K. Diehl, R. Hull, D. Morton, Rudolf Pfister, Y. Rabemampianina, David Smith, J. Vidal, C. Vorstenbosch (2001)
A good practice guide to the administration of substances and removal of blood, including routes and volumesJournal of Applied Toxicology, 21
Eun-Jung Park, Eunjoo Bae, J. Yi, Younghun Kim, Kyunghee Choi, Sang Lee, Junheon Yoon, Byung-Chun Lee, Kwangsik Park (2010)
Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles.Environmental toxicology and pharmacology, 30 2
S. Chakravarty, M. Herkenham (2005)
Toll-Like Receptor 4 on Nonhematopoietic Cells Sustains CNS Inflammation during Endotoxemia, Independent of Systemic CytokinesThe Journal of Neuroscience, 25
(2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaquesNature, 586
Ravi Danielsson, H. Eriksson (2021)
Aluminium adjuvants in vaccines - A way to modulate the immune response.Seminars in cell & developmental biology
(World Health Organization (WHO) (2013). Guidelines on the evaluation of vaccine adjuvants and adjuvanted vaccine, Technical Report Series No 987, Annex 2. Geneva. Available online: 〈https://www.who.int/publications/m/item/nonclinical-evaluation-of-vaccine-adjuvants-and-adjuvanted-vaccines-annex-2-trs-no-987〉.)
World Health Organization (WHO) (2013). Guidelines on the evaluation of vaccine adjuvants and adjuvanted vaccine, Technical Report Series No 987, Annex 2. Geneva. Available online: 〈https://www.who.int/publications/m/item/nonclinical-evaluation-of-vaccine-adjuvants-and-adjuvanted-vaccines-annex-2-trs-no-987〉.World Health Organization (WHO) (2013). Guidelines on the evaluation of vaccine adjuvants and adjuvanted vaccine, Technical Report Series No 987, Annex 2. Geneva. Available online: 〈https://www.who.int/publications/m/item/nonclinical-evaluation-of-vaccine-adjuvants-and-adjuvanted-vaccines-annex-2-trs-no-987〉., World Health Organization (WHO) (2013). Guidelines on the evaluation of vaccine adjuvants and adjuvanted vaccine, Technical Report Series No 987, Annex 2. Geneva. Available online: 〈https://www.who.int/publications/m/item/nonclinical-evaluation-of-vaccine-adjuvants-and-adjuvanted-vaccines-annex-2-trs-no-987〉.
(2020)
Growth Chart SD Rat. Available Online: 〈https://www.criver.com/ products-services/find-model/sas-sprague-dawleyrat?region=3616〉 (accessed on 30 November 2020)
(1962)
Organization for Economic Cooperation and DevelopmentInternational Organization, 16
Yury Valdés-Balbín, Darielys Santana-Mederos, Lauren Quintero, S. Fernandez, Laura Rodriguez, B. Ramírez, Rocmira Perez, Claudia Acosta, Y. Méndez, M. Ricardo, Tays Hernández, Gretchen Bergado, Franciscary Pi, A. Valdes, T. Carmenate, Ubel Ramírez, R. Oliva, J. Soubal, Raine Garrido, Félix Cardoso, M. Landys, H. González, M. Fariñas, J. Enriquez, E. Noa, A. Suarez, Cheng Fang, L. Espinosa, Y. Ramos, L. González, Yanet Climent, G. Rojas, Ernesto Relova-Hernández, Y. Infante, Sum Losada, T. Boggiano, E. Ojito, K. Monzón, F. Chiodo, F. Paquet, Guang-Wu Chen, Daniel Rivera, D. García-Rivera, V. Verez-Bencomo (2021)
SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studiesbioRxiv
Brian Quinlan, H. Mou, Lizhou Zhang, Yan Guo, Wenhui He, Amrita Ojha, M. Parcells, G. Luo, Wenhui Li, Guocai Zhong, H. Choe, M. Farzan (2020)
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancementbioRxiv
F. Verdier (2002)
Non-clinical vaccine safety assessment.Toxicology, 174 1
Yulieé López, J. Infante, S. Sifontes, D. Díaz, Viviana Pérez, G. Año, Tamara Hernández, S. Fernandez, J. Castaño, B. Cedré, Reynaldo Oliva, Luis García, R. Solís, A. Talavera (2011)
Pharmacology and toxicology of an oral tablet whole cells inactivated cholera vaccine in Sprague Dawley rats.Vaccine, 29 19
S. Sotocinal, R. Sorge, A. Zaloum, A. Tuttle, Loren Martin, J. Wieskopf, Josiane Mapplebeck, Peng Wei, S. Zhan, Shuren Zhang, J. McDougall, Oliver King, J. Mogil (2011)
The Rat Grimace Scale: A partially automated method for quantifying pain in the laboratory rat via facial expressionsMolecular Pain, 7
(2005)
Guidelines on nonclinical evaluation of vaccine
(World Health Organization (WHO) (2020) Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine. Available Online: 〈https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/accelerating-a-safe-and-effective-covid-19-vaccine〉. (Accessed on Nov 30 2020).)
World Health Organization (WHO) (2020) Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine. Available Online: 〈https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/accelerating-a-safe-and-effective-covid-19-vaccine〉. (Accessed on Nov 30 2020).World Health Organization (WHO) (2020) Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine. Available Online: 〈https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/accelerating-a-safe-and-effective-covid-19-vaccine〉. (Accessed on Nov 30 2020)., World Health Organization (WHO) (2020) Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine. Available Online: 〈https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/accelerating-a-safe-and-effective-covid-19-vaccine〉. (Accessed on Nov 30 2020).
(2019)
Local tolerance study of the VA-MENGOC-BC antimeningococcal vaccine in Sprague Dawley rats. Evaluation at 24 and 36 months of shelf
(2020)
guidance-documents/development-and-licensure-vaccines-prevent- covid-19
(2011)
American Veterinary Medical Association. AVMA Guides for euthanasia of animals
Hui Wang, Yuntao Zhang, Baoying Huang, Wei Deng, Yaru Quan, Wenling Wang, Wenbo Xu, Yuxiu Zhao, Na Li, Jin Zhang, Hongyang Liang, L. Bao, Yanfeng Xu, L. Ding, Wei-min Zhou, Hong Gao, Jiangning Liu, P. Niu, Li Zhao, Wei Zhen, H. Fu, Shouzhi Yu, Zhengli Zhang, Guangxue Xu, Changgui Li, Z. Lou, Miao Xu, C. Qin, Guizhen Wu, G. Gao, W. Tan, Xiaoming Yang (2020)
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2Cell, 182
Update on WHO Solidarity Trial -Accelerating a safe and effective COVID-19 vaccine
U. Nygaard, M. Løvik (2002)
Blood and spleen lymphocytes as targets for immunotoxic effects in the rat--a comparison.Toxicology, 174 3
J. Cavagnaro (2002)
Preclinical safety evaluation of biotechnology-derived pharmaceuticalsNature Reviews Drug Discovery, 1
(2021)
SARS-CoV-2 RBD-tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studiesACS Chem Biol, 16
B. Santos, S. Bungău, C. Pérez, Yanet Nápoles, J. Bourzac, Reinaldo Hernandez, Wendy González, G. Cioca, L. Aleya, V. González (2019)
Immuno-toxicological Evaluation of the Adjuvant Formulations for Experimental Anti-meningococcal Vaccines without Aluminium HydroxideRevista de Chimie
L. Lillie, N. Temple, L. Florence (1996)
Reference values for young normal Sprague-Dawley rats: weight gain, hematology and clinical chemistryHuman & Experimental Toxicology, 15
Development and Licensure of Vaccines to Prevent COVID-19. Guidance for Industry
Reynaldo Oliva, N. Fraleigh, Jordan Lewicky, M. Fariñas, Tamara Hernández, Alexandrine Martel, Ingrid Navarro, García-Rivera Dagmar, R. Acevedo, Hoang-Thanh Le (2019)
Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley RatsPharmaceutics, 11
(1997)
Food and Drug Administration (FDA), 2020, Nonclinical Safety Evaluation of the Immunotoxic Potential of Drugs and Biologics Guidance for Industry
P. Baldrick, D. Richardson, G. Elliott, A. Wheeler (2002)
Safety evaluation of monophosphoryl lipid A (MPL): an immunostimulatory adjuvant.Regulatory toxicology and pharmacology : RTP, 35 3
(1999)
Humane endpoints in animal experimentation for biomedical research: Ethical, legal and practical aspects
(World Health Organization (WHO) (2012). Guidance for immunotoxicity risk assessment for chemicals. IPCS harmonization project document; no. 10. Available online: 〈www.who.int/ipcs/methods/harmonization/areas/guidance_immunotoxicity.pdf?ua=1〉.)
World Health Organization (WHO) (2012). Guidance for immunotoxicity risk assessment for chemicals. IPCS harmonization project document; no. 10. Available online: 〈www.who.int/ipcs/methods/harmonization/areas/guidance_immunotoxicity.pdf?ua=1〉.World Health Organization (WHO) (2012). Guidance for immunotoxicity risk assessment for chemicals. IPCS harmonization project document; no. 10. Available online: 〈www.who.int/ipcs/methods/harmonization/areas/guidance_immunotoxicity.pdf?ua=1〉., World Health Organization (WHO) (2012). Guidance for immunotoxicity risk assessment for chemicals. IPCS harmonization project document; no. 10. Available online: 〈www.who.int/ipcs/methods/harmonization/areas/guidance_immunotoxicity.pdf?ua=1〉.
A. Kandeil, A. Mostafa, Rehab Hegazy, R. El-Shesheny, Ahmed Taweel, M. Gomaa, Mahmoud Shehata, M. Elbaset, A. Kayed, Sara Mahmoud, Yassmin Moatasim, Omnia Kutkat, N. Yassen, Marwa Shabana, M. Gaballah, M. Kamel, Noura Shama, M. Sayes, Amira Ahmed, Zahraa Elalfy, Bassim Mohamed, Safa El-Fattah, Hazem hariri, M. Kader, O. Azmy, G. Kayali, M. Ali (2021)
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical StudiesVaccines, 9
(2012)
Guidance for immunotoxicity risk assessment for chemicals. IPCS harmonization project document
(2011)
Charles River , Growth Chart SD Rat
Toxicology – Unpaywall
Published: Mar 29, 2022
Access the full text.
Sign up today, get DeepDyve free for 14 days.